SREBF2 and metabolic dysfunction-associated steatotic liver disease: However, even though such a mechanism would be involved, we cannot yet exclude other mechanisms for the action of statins such as an effect on mitochondrial fatty acid oxidation [90], SREBP-2 (sterol regulatory element binding transcription factor 2) induced autophagy [91], and others [92,93,94], to be effective in NAFLD [95,96,97,98,99].